---
title: Bachem vs Dipharma
slug_a: bachem
slug_b: dipharma
site: cdmo
review_signal_gate: closed
canonical_path: /compare/bachem/dipharma
---

# Bachem vs Dipharma

Side-by-side profile data from each company listing on this directory.

## Bachem

- Profile: [/companies/bachem](/companies/bachem)

Bachem — Global leader in peptide and oligonucleotide development and manufacturing, offering GMP-compliant clinical and commercial supply from early research through commercial scale.

Services: 9. Modalities: 2. Indications: 0. Locations: 8. Certifications: 18. The strongest documented coverage currently appears in certifications (18).

### Services

- API Synthesis & Manufacturing
- Oligonucleotide Manufacturing
- Peptide Manufacturing
- Process Development
- Formulation Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- CMC Regulatory Submission Support

### Modalities

- Oligonucleotide
- Peptide

### Development capabilities

- Analytical method development
- Formulation development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)

## Dipharma

- Profile: [/companies/dipharma](/companies/dipharma)

Dipharma — Global CDMO and API manufacturer with 600 employees, 4 cGMP plants, and 75+ years of experience in hazardous chemical synthesis, offering exclusive synthesis services and catalogue APIs with FDA, AIFA, and PMDA inspections since 1970.

Services: 6. Modalities: 1. Indications: 0. Locations: 3. Certifications: 0. The strongest documented coverage currently appears in services (6).

### Services

- API Synthesis & Manufacturing
- Process Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- CMC Regulatory Submission Support

### Modalities

- Small Molecule

### Development capabilities

- Analytical method development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)